Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teprenone for Glucocorticoid-Induced Gastrointestinal Injury in SLE
NCT07654049Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jun 2026
- Primary completion
- Jun 2027
01
Overview
Randomised, open-label trial of teprenone in Gastrointestinal injury (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Global Overall Symptom Scale at 12 weeks. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
teprenone
03
Conditions
Gastrointestinal injury
Beyond the preview
Go deeper on NCT07654049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07654049.